Thu May 19 15:17:13 2022
EVENTS
 FREE
SOFTWARE
INSTITUTE

POLITICS
JOBS
MEMBERS'
CORNER

MAILING
LIST

NYLXS Mailing Lists and Archives
NYLXS Members have a lot to say and share but we don't keep many secrets. Join the Hangout Mailing List and say your peice.

DATE 2017-06-01

HANGOUT

2022-05-19 | 2022-04-19 | 2022-03-19 | 2022-02-19 | 2022-01-19 | 2021-12-19 | 2021-11-19 | 2021-10-19 | 2021-09-19 | 2021-08-19 | 2021-07-19 | 2021-06-19 | 2021-05-19 | 2021-04-19 | 2021-03-19 | 2021-02-19 | 2021-01-19 | 2020-12-19 | 2020-11-19 | 2020-10-19 | 2020-09-19 | 2020-08-19 | 2020-07-19 | 2020-06-19 | 2020-05-19 | 2020-04-19 | 2020-03-19 | 2020-02-19 | 2020-01-19 | 2019-12-19 | 2019-11-19 | 2019-10-19 | 2019-09-19 | 2019-08-19 | 2019-07-19 | 2019-06-19 | 2019-05-19 | 2019-04-19 | 2019-03-19 | 2019-02-19 | 2019-01-19 | 2018-12-19 | 2018-11-19 | 2018-10-19 | 2018-09-19 | 2018-08-19 | 2018-07-19 | 2018-06-19 | 2018-05-19 | 2018-04-19 | 2018-03-19 | 2018-02-19 | 2018-01-19 | 2017-12-19 | 2017-11-19 | 2017-10-19 | 2017-09-19 | 2017-08-19 | 2017-07-19 | 2017-06-19 | 2017-05-19 | 2017-04-19 | 2017-03-19 | 2017-02-19 | 2017-01-19 | 2016-12-19 | 2016-11-19 | 2016-10-19 | 2016-09-19 | 2016-08-19 | 2016-07-19 | 2016-06-19 | 2016-05-19 | 2016-04-19 | 2016-03-19 | 2016-02-19 | 2016-01-19 | 2015-12-19 | 2015-11-19 | 2015-10-19 | 2015-09-19 | 2015-08-19 | 2015-07-19 | 2015-06-19 | 2015-05-19 | 2015-04-19 | 2015-03-19 | 2015-02-19 | 2015-01-19 | 2014-12-19 | 2014-11-19 | 2014-10-19 | 2014-09-19 | 2014-08-19 | 2014-07-19 | 2014-06-19 | 2014-05-19 | 2014-04-19 | 2014-03-19 | 2014-02-19 | 2014-01-19 | 2013-12-19 | 2013-11-19 | 2013-10-19 | 2013-09-19 | 2013-08-19 | 2013-07-19 | 2013-06-19 | 2013-05-19 | 2013-04-19 | 2013-03-19 | 2013-02-19 | 2013-01-19 | 2012-12-19 | 2012-11-19 | 2012-10-19 | 2012-09-19 | 2012-08-19 | 2012-07-19 | 2012-06-19 | 2012-05-19 | 2012-04-19 | 2012-03-19 | 2012-02-19 | 2012-01-19 | 2011-12-19 | 2011-11-19 | 2011-10-19 | 2011-09-19 | 2011-08-19 | 2011-07-19 | 2011-06-19 | 2011-05-19 | 2011-04-19 | 2011-03-19 | 2011-02-19 | 2011-01-19 | 2010-12-19 | 2010-11-19 | 2010-10-19 | 2010-09-19 | 2010-08-19 | 2010-07-19 | 2010-06-19 | 2010-05-19 | 2010-04-19 | 2010-03-19 | 2010-02-19 | 2010-01-19 | 2009-12-19 | 2009-11-19 | 2009-10-19 | 2009-09-19 | 2009-08-19 | 2009-07-19 | 2009-06-19 | 2009-05-19 | 2009-04-19 | 2009-03-19 | 2009-02-19 | 2009-01-19 | 2008-12-19 | 2008-11-19 | 2008-10-19 | 2008-09-19 | 2008-08-19 | 2008-07-19 | 2008-06-19 | 2008-05-19 | 2008-04-19 | 2008-03-19 | 2008-02-19 | 2008-01-19 | 2007-12-19 | 2007-11-19 | 2007-10-19 | 2007-09-19 | 2007-08-19 | 2007-07-19 | 2007-06-19 | 2007-05-19 | 2007-04-19 | 2007-03-19 | 2007-02-19 | 2007-01-19 | 2006-12-19 | 2006-11-19 | 2006-10-19 | 2006-09-19 | 2006-08-19 | 2006-07-19 | 2006-06-19 | 2006-05-19 | 2006-04-19 | 2006-03-19 | 2006-02-19 | 2006-01-19 | 2005-12-19 | 2005-11-19 | 2005-10-19 | 2005-09-19 | 2005-08-19 | 2005-07-19 | 2005-06-19 | 2005-05-19 | 2005-04-19 | 2005-03-19 | 2005-02-19 | 2005-01-19 | 2004-12-19 | 2004-11-19 | 2004-10-19 | 2004-09-19 | 2004-08-19 | 2004-07-19 | 2004-06-19 | 2004-05-19 | 2004-04-19 | 2004-03-19 | 2004-02-19 | 2004-01-19 | 2003-12-19 | 2003-11-19 | 2003-10-19 | 2003-09-19 | 2003-08-19 | 2003-07-19 | 2003-06-19 | 2003-05-19 | 2003-04-19 | 2003-03-19 | 2003-02-19 | 2003-01-19 | 2002-12-19 | 2002-11-19 | 2002-10-19 | 2002-09-19 | 2002-08-19 | 2002-07-19 | 2002-06-19 | 2002-05-19 | 2002-04-19 | 2002-03-19 | 2002-02-19 | 2002-01-19 | 2001-12-19 | 2001-11-19 | 2001-10-19 | 2001-09-19 | 2001-08-19 | 2001-07-19 | 2001-06-19 | 2001-05-19 | 2001-04-19 | 2001-03-19 | 2001-02-19 | 2001-01-19 | 2000-12-19 | 2000-11-19 | 2000-10-19 | 2000-09-19 | 2000-08-19 | 2000-07-19 | 2000-06-19 | 2000-05-19 | 2000-04-19 | 2000-03-19 | 2000-02-19 | 2000-01-19 | 1999-12-19

Key: Value:

Key: Value:

MESSAGE
DATE 2017-06-12
FROM From: "APhA's Pharmacy Today"
SUBJECT Subject: [Hangout - NYLXS] =?utf-8?q?June_12=2C_2017=3A_Opioid_Crisis_Comp?=
From hangout-bounces-at-nylxs.com Mon Jun 12 13:06:19 2017
Return-Path:
X-Original-To: archive-at-nylxs.com
Delivered-To: archive-at-nylxs.com
Received: from www.mrbrklyn.com (www.mrbrklyn.com [96.57.23.82])
by mrbrklyn.com (Postfix) with ESMTP id 31F92163F57;
Mon, 12 Jun 2017 13:06:19 -0400 (EDT)
X-Original-To: hangout-at-www.mrbrklyn.com
Delivered-To: hangout-at-www.mrbrklyn.com
Received: by mrbrklyn.com (Postfix, from userid 1000)
id 64951163F56; Mon, 12 Jun 2017 13:06:16 -0400 (EDT)
Resent-From: Ruben Safir
Resent-Date: Mon, 12 Jun 2017 13:06:16 -0400
Resent-Message-ID: <20170612170616.GB26952-at-www.mrbrklyn.com>
Resent-To: hangout-at-mrbrklyn.com
X-Original-To: ruben-at-mrbrklyn.com
Delivered-To: ruben-at-mrbrklyn.com
Received: from mail79-155.us1.msgfocus.com (mail79-155.us1.msgfocus.com
[81.29.79.155]) by mrbrklyn.com (Postfix) with ESMTP id 167B2160876
for ; Mon, 12 Jun 2017 09:52:02 -0400 (EDT)
DKIM-Signature: v=1; a=rsa-sha1; c=relaxed/relaxed; s=msgf; d=msgfocus.com;
h=Subject:Message-ID:Reply-To:X-Mailer:To:List-Unsubscribe:From:Date:MIME-Version:Content-Type;
bh=SAFW+vCkUx3m50RLaG8jCNL9e40=;
b=P8sBLhhBaNST2kw5oO/yXIoNZk3ezH+kNkUL4jPIMpp7eDAWkRzJ4UysXTL/FcB87bulvinVcY7I
M22phlZfIrpTEzk+m/FQ6i/B4nWukvUJ8ypobYpxhBLyPsMpk5FYmWpmj8erxBcUqzsTAZ8Z78o7
QsNKVp7GkN2XFuTRK2E=
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=aphanet.org; s=hrs-dkim;
t=1497275521; bh=/fvz9/VSzk93VCXCi6iIiEGuHoxKvKaHkXvZVyLxf6Q=;
h=Subject:Message-ID:Reply-To:X-Mailer:To:List-Unsubscribe:From:
Date:MIME-Version:Content-Type;
b=jTqYLZc7ZKKvwWDQ42o8mX10iMbqSqhfDjfz8cOw2fXvPow94Fp1Tg32om+xyXKlQ
eBE0l5FAiuOwRuXLSMfDboWeiww9kKqCRq1sC42wwUKrOr6mPwR/v0SQjsDCQNW0Y3
EAmb2u+fSHXDAGe9oGTzx1RRrOkHbKisMtxzW4rE=
Message-ID:
X-Mailer: MessageFocus v2 launch
To: ruben-at-mrbrklyn.com
From: "APhA's Pharmacy Today"
Date: Mon, 12 Jun 2017 14:52:01 +0100
MIME-Version: 1.0
Subject: [Hangout - NYLXS] =?utf-8?q?June_12=2C_2017=3A_Opioid_Crisis_Comp?=
=?utf-8?q?licates_GOP=E2=80=99s_Health_Law_Push?=
X-BeenThere: hangout-at-nylxs.com
X-Mailman-Version: 2.1.17
Precedence: list
Reply-To: APhA's Pharmacy Today
List-Id: NYLXS Tech Talk and Politics
List-Unsubscribe: ,

List-Post:
List-Help:
List-Subscribe: ,

Content-Type: multipart/mixed; boundary="===============1236529168=="
Errors-To: hangout-bounces-at-nylxs.com
Sender: "Hangout"


--===============1236529168==
Content-Type: multipart/alternative; boundary="--19B22B36DBE374DE6A2953414C"


----19B22B36DBE374DE6A2953414C
Content-Type: text/plain; charset="UTF-8"
Content-Transfer-Encoding: quoted-printable

Pharmacy Today

http://apha.msgfocus.com/q/17M5Vd9XzezrvlFKijpEuh/wv
jfps-savedate-728
http://apha.msgfocus.com/c/1dDzAWS6y7YS0LggWMePHycks
Banner JUNE 12, 2017 Top Story logo Opioid Crisis Complicates GOP=E2=80=99s=
Health Law Push Wall Street Journal (06/12/17) Nunn, Sharon The nation=E2=
=80=99s worsening opioid crisis has made key Republican senators hesitate t=
o support legislation dismantling major portions of the Affordable Care Act=
(ACA). Several provisions of the ACA allowed millions of Americans seeking=
substance-abuse treatment to gain coverage, including through an expansion=
of the Medicaid health program. But the House bill repealing the ACA, pass=
ed in early May, would roll back that Medicaid expansion beginning in 2020 =
and allow...
http://apha.msgfocus.com/c/1dDzEWdrYRkmYK0sOlDbqwOq3

emerinsulin-160
http://apha.msgfocus.com/c/1dDzIVyNpAFRWIKEFV1x9vqvE

Drugs & Diseases
logo

=E2=96=AA
Seizing on opioid crisis, a drug maker lobbies hard for its product

=E2=96=AA
WHO targets antimicrobial resistance in new essential medicines list

=E2=96=AA
Mismatch-repair deficiency predicts response of solid tumors to PD-1 blocka=
de

=E2=96=AA
Chi-Med steps closer to Chinese pharma first with drug filing

Practice & Trends
logo

=E2=96=AA
Opioid dealers embrace the dark web to send deadly drugs

=E2=96=AA
Pfizer hikes U.S. prices of 91 drugs by average 20% in 2017

=E2=96=AA
Dietary supplement industry outlines new pedigree protocol

=E2=96=AA
Robotic pharmacy to open at Kirkland Cancer Center

Laws, Regs & Rulings
logo

=E2=96=AA
States lead the fight against Trump's contraception rollback

=E2=96=AA
NJ governor approves law expanding pharmacy access to opioid antidote

=E2=96=AA
Lower drug costs still 'absolute priority' for Trump, Price says

News You Can Use

http://apha.msgfocus.com/c/1dDzMUU8Qk1mUHuQxupSSu2Bf

=E2=96=AA
FDA=E2=80=99s new codeine and tramadol warning further restricts use in kids
http://apha.msgfocus.com/c/1dDzQUfuh3mRSGf2p3OeBsEGQ
=E2=96=AA
Misuse and abuse of noncontrolled drugs: It=E2=80=99s not just prescription=
opioids anymore
http://apha.msgfocus.com/c/1dDzUTAPHMImQEZegDcAkrgMr

http://apha.msgfocus.com/c/1dDzYSWb8w3RODJq8cAW3pSS2

=E2=96=AA
FDA approves first generics of atomoxetine (Strattera) for treatment of ADHD
http://apha.msgfocus.com/c/1dDA2ShwzfpmMCtBZLZhMouXD

http://apha.msgfocus.com/c/1dDAaQYdqI6mIzXZIULZelJ8P

=E2=96=AA
The impact of a retail prescription synchronization program on medication a=
dherence
http://apha.msgfocus.com/c/1dDAeQjyRrrRGyIbAuakXkleq

http://apha.msgfocus.com/c/1dDAiPEUiaNmExsns3yGGiXk1

=E2=96=AA
Report of the APhA Stakeholder Conference on Improving Patient Access to In=
jectable Medications
http://apha.msgfocus.com/c/1dDAmP0fIU8RCwczjCX2phzpC

http://apha.msgfocus.com/c/1dDAqOlB9DumAuWLbclo8gbvd

=E2=96=AA
Resource Guide for Immunization Services
http://apha.msgfocus.com/c/1dDAuNGWAmPRytGX2LJJReNAO

junebom
http://apha.msgfocus.com/c/1dDAyN2i16bmwsr8Ul85AdpGp

PT_May2017_Cover
http://apha.msgfocus.com/c/1dDACMnDrPwRurbkLUwrjc1M0

Top Story

Opioid Crisis Complicates GOP=E2=80=99s Health Law Push
Wall Street Journal (06/12/17) Nunn, Sharon

The nation=E2=80=99s worsening opioid crisis has made key Republican senato=
rs hesitate to support legislation dismantling major portions of the Afford=
able Care Act (ACA). Several provisions of the ACA allowed millions of Amer=
icans seeking substance-abuse treatment to gain coverage, including through=
an expansion of the Medicaid health program. But the House bill repealing =
the ACA, passed in early May, would roll back that Medicaid expansion begin=
ning in 2020 and allow insurance companies to charge some people with drug =
addictions higher premiums or deny them substance-abuse coverage. Concerns =
about those provisions cut into Republican support for the replacement meas=
ure in the House. Of the 20 Republicans who voted against the House bill, 1=
6 represent states that saw significant increases in drug-overdose death ra=
tes in recent years. Now, the same concerns are emerging as a factor as the=
Senate takes up the House bill and ponders how to change it. Some Republic=
an senators are pushing to wind down the Medicaid expansion funding more sl=
owly. They would have the rollback occur over a 7-year window beginning in =
2020. Lawmakers are also looking at including a pot of money specifically f=
or opioid treatment, according to Republican senate aides.

Read More
http://apha.msgfocus.com/c/1dDAGLIYSySmspVwDtUN2aDRB | Return to Headlines

Drugs & Diseases

Seizing on opioid crisis, a drug maker lobbies hard for its product
New York Times (06/12/17) Goodnough, Abby; Zernike, Kate

Drug manufacturer Alkermes has spent years targeting lawmakers and law enfo=
rcement strategies, lobbying them about the benefits of its naltrexone (Viv=
itrol) drug as a treatment for opioid addiction. Now, its sales and profile=
are rising fast, thanks to its manufacturers=E2=80=99 shrewd use of politi=
cal connections, and despite scant science to prove the drug=E2=80=99s effi=
cacy. Last month, HHS Secretary Tom Price, praised it as the future of opio=
id addiction treatment after visiting the company=E2=80=99s plant in Ohio. =
He set off a furor among substance abuse specialists by criticizing its les=
s expensive and more widely used and rigorously studied competitors, bupren=
orphine and methadone, as medications that "simply substitute" for illicit =
drugs. With the Trump administration sending $1 billion in new addiction pr=
evention and treatment funds to states over the next 2 years through the 21=
st Century Cures Act, Alkermes's marketing has shifted into even higher gea=
r. Nearly 700 experts in the field recently wrote a letter to Price asserti=
ng that some the company's marketing tactics ignore widely accepted science=
. Alkermes executives say they welcome any addiction treatment. They have p=
resented their drug as a cleaner alternative to buprenorphine.

Read More
http://apha.msgfocus.com/c/1dDAKL4kjidRqoFIv3j8L9fXc | Return to Headlines

WHO targets antimicrobial resistance in new essential medicines list
British Medical Journal (06/09/17) Gulland, Anne

The World Health Organization says the antibiotics colistin and some cephal=
osporins should only be used when all other treatments have failed, in an e=
ffort to combat anti-microbial resistance. In the latest edition of its ess=
ential medicines list, updated every 2 years, WHO has grouped antibiotics i=
nto three groups=E2=80=94access, watch, and reserve=E2=80=94indicating whic=
h can be used for common infections and which should only be used in rare c=
ircumstances. WHO recommends that antibiotics in the access group, which in=
cludes amoxicillin, be available at all times to treat common conditions. T=
he watch group includes antibiotics that are recommended as first or second=
choice treatments for a small number of infections. In this group are cipr=
ofloxacin to treat cystitis and upper respiratory tract infections which, W=
HO says, should be dramatically reduced to avoid further development of res=
istance. The third group, reserve, includes antibiotics that should be cons=
idered last resort options and used only when all other drugs have failed, =
such as for life threatening infections from multidrug resistant bacteria.

Read More
http://apha.msgfocus.com/c/1dDASJL1aKURmma6ec5Qd6u8o | Return to Headlines

Mismatch-repair deficiency predicts response of solid tumors to PD-1 blocka=
de
Science (06/08/17) Le, Dung T.; Durham, Jennifer N.; Smith, Kellie N.; et a=
l.

In a new study, researchers report the expansion of a proof-of-concept stud=
y that found that colorectal cancers with mismatch repair (MMR) deficiency =
were sensitive to immune checkpoint blockade with anti-PD-1 antibodies. The=
new study evaluated the efficacy of PD-1 blockade in patients with advance=
d MMR-deficient cancers for 12 different tumor types. The data show that ob=
jective radiographic responses were seen in more than one-half (53%) of the=
patients, while 21% achieved complete responses. The responses, they note,=
were durable with median progression-free and overall survival still not r=
eached. Functional analysis in a responding patient revealed rapid in vivo =
expansion of neoantigen-specific T cell clones that were reactive to mutant=
neopeptides found in the tumor. According to the researchers, the findings=
"support the hypothesis that the large proportion of mutant neoantigens in=
MMR-deficient cancers make them sensitive to immune checkpoint blockade, r=
egardless of the cancers' tissue of origin."

Read More
http://apha.msgfocus.com/c/1dDAWJ6mBugmkkUi5LubW56dZ | Return to Headlines

Chi-Med steps closer to Chinese pharma first with drug filing
Reuters (06/12/17)

Hutchison China MediTech, the Shanghai-based drugmaker listed in London, re=
ported on Monday that China's Food and Drug Administration will now review =
its cancer medicine fruquintinib as a treatment for advanced colorectal can=
cer. The move triggers a milestone payment of $4.5 million from U.S. partne=
r Eli Lilly to the Chinese firm, which is commonly known as Chi-Med.
Chi-Med and Lilly also aim to win approval for fruquintinib in the United S=
tates, which would make it the first modern drug developed in China to be s=
old on the international market. Hopes for the drug, which starves tumors o=
f blood supply, received a major boost in March when a late-stage clinical =
trial produced strongly positive results in colon cancer. The drug is also =
being developed for non-small cell lung cancer and another study in gastric=
cancer is due to start soon.

Read More
http://apha.msgfocus.com/c/1dDB0IrI2dBRijEtXkSxF3IjA | Return to Headlines

Practice & Trends

Opioid dealers embrace the dark web to send deadly drugs
New York Times (06/11/17) Popper, Nathaniel

In a growing number of arrests and opioid overdoses, law enforcement offici=
als say, the drugs are being bought online. Internet sales have allowed pow=
erful synthetic opioids such as fentanyl to reach people through small pack=
ages in the mail. The authorities have been frustrated in their efforts to =
crack down on the trade because these sites generally exist on the so-calle=
d dark web, where buyers can visit anonymously using special browsers and m=
ake purchases with virtual currencies like Bitcoin. Largely because of thei=
r potency, synthetic opioids have become the fastest-growing cause of the o=
verdose epidemic. Just a few flakes of fentanyl can be fatal. Their deadly =
efficiency also makes them ideal for sale online. Unlike heroin and prescri=
ption opioid analgesics, which are relatively bulky, enough fentanyl to eff=
ect nearly 50,000 people can fit in a standard first-class envelope. The au=
thorities say these markets account for a small proportion of the overall t=
raffic in most drugs. But when it comes to synthetic opioids, many authorit=
ies tracking the traffic say that dark web markets have quickly assumed a m=
ore prominent role.

Read More
http://apha.msgfocus.com/c/1dDB4HN3sWXmgioFOUgTo2kpb | Return to Headlines

Pfizer hikes U.S. prices of 91 drugs by average 20% in 2017
Reuters (06/02/17) Grover, Natalie

Pfizer has increased the list price of 91 medicines in the United States by=
an average of 20% thus far in 2017, according to a new report. Data seen b=
y the Financial Times indicate the company raised the list price of the dru=
gs by 5%=E2=80=9313% on June 1, after also increasing prices in January. A =
company spokesperson noted, "For Pfizer's U.S. biopharma business, as of th=
e first quarter, the weighted average net selling price increase year-to-da=
te is 4%," referring to prices after discounts and rebates, rather than lis=
t prices.

Read More
http://apha.msgfocus.com/c/1dDB8H8oTGiReh8RGtFf70WuM | Return to Headlines

Dietary supplement industry outlines new pedigree protocol
Drug Store News (06/01/17) Johnsen, Michael

The SIDI Work Group=E2=80=94a coalition of the Consumer Healthcare Products=
Association, the Council for Responsible Nutrition (CRN), and the United N=
atural Products Alliance=E2=80=94issued an updated draft of the "Standardiz=
ed Information on Dietary Ingredients Protocol." According to Duffy Mackay,=
chair of the SIDI Work Group executive committee and senior vice president=
, scientific and regulatory affairs, CRN, "The SIDI Work Group convened reg=
ularly over several months developing an updated draft that addresses new f=
ood safety regulations implemented since version 2.1 was released in 2008. =
We welcome comments from industry stakeholders and regulatory officials for=
consideration as we finalize this next edition of the Protocol, slated for=
release by the end of 2017." The Protocol presents an outline representing=
the type and scope of information about a dietary ingredient that an ingre=
dient supplier typically needs to provide to a manufacturer. The primary ob=
jective of the Protocol is to recommend a standard format for presenting th=
is information, so that information exchange can be done in a simplified an=
d streamlined manner. The SIDI Work Group is seeking feedback from industry=
stakeholders and regulators by July 3. The draft Protocol and comment form=
are available here
http://apha.msgfocus.com/c/1dDBcGtKkpEmcfT3y33APZyAn.

Read More
http://apha.msgfocus.com/c/1dDBgFP5L8ZRaeDfpCrWyYaFY | Return to Headlines

Robotic pharmacy to open at Kirkland Cancer Center
Jackson Sun (Tennessee) (05/20/17) Faris, Maranda

The Kirkland Cancer Center in Jackson, TN, recently opened its new robotic =
pharmacy. The pharmacy will allow medications to be mixed more accurately i=
n a liquid form and decrease the amount of waste from other forms of medica=
tion. The new pharmacy also allows more patients to visit the Jackson and t=
he Kirkland Cancer Center, rather than having to go out of state for treatm=
ents. "You don't have to go somewhere else. You may choose to, but there ar=
e many things that you can do right here at home, and this is one of the la=
test advances," West Tennessee Healthcare Foundation President Frank McMeen=
said. "You don't have to go to Houston, or Wisconsin or Ohio. It puts us i=
n a whole other league of cancer facilities." McMeen said the pharmacy is b=
eing named after Eugene Reese, MD, and his wife, Elaine. "The pharmacy has =
become more and more involved in compounding the medicines, mixing them and=
getting them ready for patients to be treated," Reese said. "The pharmacy =
has become a much more important role in the treatment of oncology patients=
than it was 40 years ago."

Read More
http://apha.msgfocus.com/c/1dDBkFarbSlm8dnrhbQihWMLz | Return to Headlines

Laws, Regs & Rulings

States lead the fight against Trump's contraception rollback
New York Times (06/10/17) Stolberg, Sheryl Gay

With the Trump administration planning to roll back the Affordable Care Act=
(ACA) mandate that employers cover contraceptives, the battle over the iss=
ue is shifting to the states. Currently, 28 states have some type of "contr=
aceptive equity" law, aimed at making it cheaper and more accessible. Gov. =
Brian Sandoval of Nevada on June 10 signed a measure requiring insurers to =
cover 12 months of contraception at a time, with no copayment. Several stat=
es are expanding access by requiring insurers to cover a year=E2=80=99s sup=
ply of contraceptives at a time, as opposed to the customary 3 months. In W=
ashington, Gov. Jay Inslee last month signed a bill that would do just that=
, and Gov. John Hickenlooper of Colorado signed a similar bill last week. L=
awmakers in Massachusetts and New York are also considering "contraceptive =
equity bills." The Trump administration has drafted a far-reaching rule tha=
t would greatly expand the number of employers and insurers that could qual=
ify for exemptions from the ACA's contraceptive mandate by claiming a moral=
or a religious objection. Hundreds of thousands of women, many of them poo=
r, could lose access to no-cost birth control if the rule goes into effect.

Read More
http://apha.msgfocus.com/c/1dDBoEvMCBGR6c7D8LeE0VoRa | Return to Headlines

NJ governor approves law expanding pharmacy access to opioid antidote
NJ Spotlight (06/12/17) Stainton, Lilo

Gov. Chris Christie of New Jersey signed a law Friday that would allow phar=
macies of all sizes to sell naloxone, which is easy to administer as a shot=
or nasal spray that can quickly reverse a potentially deadly reaction to h=
eroin or prescription drugs. "Expanding access to nalaxone will help save l=
ives and allow those who are suffering from addiction a second chance to ge=
t the treatment they need to win their battle" with the disease, said Sen. =
Joe Vitale (D-Middlesex), who first introduced a proposal to expand drug st=
ore sales in November 2015. Vitale noted access to the antidote was limited=
in the past, especially for civilians who were not first responders. "But =
the antidote can be administered safely and swiftly by others, including fa=
mily members, and providing access to it at the pharmacy can mean the diffe=
rence between life and death," he said. A growing number of community pharm=
acies, including CVS and Walgreens, announced plans last year to expand sal=
es of the medicine to patients without specific orders from a doctor to hun=
dreds of stores in New Jersey.
The new law makes clear that smaller, independent pharmacies can do the sam=
e, and directs a doctor in the ranks of the state Department of Health to s=
tep in and provide the required standing order if the pharmacy does not hav=
e a physician to do so.

Read More
http://apha.msgfocus.com/c/1dDBsDR83l2m4aRP0kCZJU0WL | Return to Headlines

Lower drug costs still 'absolute priority' for Trump, Price says
Bloomberg (06/08/17) Edney, Anna

HHS Secretary Tom Price, MD, on June 8 told the Senate Finance Committee th=
at President Trump has asked his agency for recommendations on policies tha=
t would reduce the costs of medications. Price said he instructed CMS, FDA,=
and the Health Resources and Services Administration to come up with propo=
sals. He has also been meeting with pharmacists, care providers, and PBMs i=
n recent weeks to discuss ideas for making drugs more affordable. At the Se=
nate hearing, Price declined to answer a separate question about whether th=
e administration will fund cost-sharing reduction payments made to insurers=
to help reduce low-income Americans' health expenses.

Read More
http://apha.msgfocus.com/c/1dDBACxOUNJm08mcJtpHbRf7X | Return to Headlines

Abstract News =C2=A9 Copyright 2017 INFORMATION, INC.
http://apha.msgfocus.com/c/1dDBEBTalx4QY76oB2O2UPRdy
Powered by Information, Inc.
http://apha.msgfocus.com/c/1dDBIBevMgqlW5QAsCcoDOtj9

careerctr-728
http://apha.msgfocus.com/c/1dDBMAzRcZLQU4AMkbAKmN5oK

http://apha.msgfocus.com/c/1dDBQzVcDJ7lS3kYbKZ65LHul

----19B22B36DBE374DE6A2953414C
Content-Type: text/html; charset="UTF-8"
Content-Transfer-Encoding: quoted-printable


"http://www.w3.org/TR/html4/loose.dtd">



Pharmacy Today




width=3D"728">
=20=20=20=20
>=20=20=20=20=20=20=20=20
g=3D0 width=3D"728">


=20=20=20=20











=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20















=20

:center;" id=3D"TDLinkBar" bgcolor=3D"#ffffff" valign=3D"top" colspan=3D"2"=
align=3D"center">
vlFKijpEuh/wv">View this email online.
inkBar" bgcolor=3D"#ffffff" valign=3D"top" colspan=3D"2">
rOKjzW" target=3D"_blank">s/JFPS-2017-Save-The-Date-728x90.png" hspace=3D"0" vspace=3D"0" border=3D"0=
" alt=3D"jfps-savedate-728" />



ef=3D"http://apha.msgfocus.com/c/1dDBYyBTvbOlO0PlUTLNxIVFx" target=3D"_blan=
k" alt=3D"APhA Logo">

mages/banner.jpg" alt=3D"Banner" width=3D"728" height=3D"190" hspace=3D"0" =
vspace=3D"0" border=3D"0" usemap=3D"#bannerMap">


ing=3D"0" border=3D"0">







&=
nbsp;

ong>JUNE 12, 2017  
olspan=3D"2" style=3D"height: 5px;">




" >
ing=3D"0" border=3D"0">






idth=3D"728">
apha_daily/images/top-story.gif" border=3D"0" alt=3D"Top Story" width=3D"72=
8" height=3D"39" />

"0" cellpadding=3D"0" border=3D"0">




ign=3D"top" width=3D"350" style=3D"padding: 0px;">
n-bottom:10px;">
c=3D"http://www.infoinc.com/apha_daily/images/library/1998/laws-3_lg.jpg" a=
lt=3D"logo" hspace=3D"0" vspace=3D"0" border=3D"0" style=3D"padding:0px;max=
-width:350px;" width=3D"350" />


=20=20=20=20=
=20=20=20=20
le=3D"padding: 5px;" valign=3D"top" width=3D"378">
O=
pioid Crisis Complicates GOP’s Health Law Push

Wall=
Street Journal (06/12/17) Nunn, Sharon


The nation’s=
worsening opioid crisis has made key Republican senators hesitate to suppo=
rt legislation dismantling major portions of the Affordable Care Act (ACA).=
Several provisions of the ACA allowed millions of Americans seeking substa=
nce-abuse treatment to gain coverage, including through an expansion of the=
Medicaid health program. But the House bill repealing the ACA, passed in e=
arly May, would roll back that Medicaid expansion beginning in 2020 and all=
ow... Read More
=3D"margin-top:5px; line-height: 1.75">


=20=
=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=
=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20
=20=20=20=20=20=20=20=20=20=
=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20


0 cellpadding=3D0 width=3D"728">




;" id=3D"TDLinkBar" bgcolor=3D"#82C2DB" width=3D"160" valign=3D"top">

9gHxL8" target=3D"_blank">s/16590__160x600.png" hspace=3D"0" vspace=3D"0" border=3D"0" alt=3D"emerins=
ulin-160" />



; padding-top: 0px; padding-left: 0px;" id=3D"TDLinkBar" bgcolor=3D"#ffffff=
" valign=3D"top" width=3D"565" >

"0" cellpadding=3D"0" border=3D"0">



0">






0">






0">



le=3D"padding: 0px; padding-left: 5px; padding-top: 0px; padding-bottom: 5p=
x;" colspan=3D"2" align=3D"center">
infoinc.com/apha_daily/images/drugs-diseases.gif" vspace=3D"0" hspace=3D"0"=
border=3D"0" alt=3D"Drugs & Diseases" />
le=3D"padding: 0px; padding-left: 5px; padding-bottom: 5px;">
p://www.infoinc.com/apha_daily/images/library/1997/drugs-10.jpg" alt=3D"log=
o" hspace=3D"0" vspace=3D"0" border=3D"0" style=3D"padding:0px;max-width:12=
6px;" width=3D"126" />


padding: 5px;" id=3D"TDLinkBar" bgcolor=3D"#ffffff">
ellspacing=3D"0" cellpadding=3D"0" border=3D"0">=20=20=20=20=20=20=20=20=20=
=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=
=20=20=20=20=20=20=20=20




























dding: 0px;padding-right: 0px;" valign=3D"top">
 τ=
2; 
dding: 0px;padding-bottom: 2px;" valign=3D"top" height=3D"15">
#934040">Seizing on opioid crisis, a drug maker lobbies hard for its produc=
t

2"> 
dding: 0px;padding-right: 0px;" valign=3D"top">
 τ=
2; 
dding: 0px;padding-bottom: 2px;" valign=3D"top" height=3D"15">
#934057">WHO targets antimicrobial resistance in new essential medicines li=
st

2"> 
dding: 0px;padding-right: 0px;" valign=3D"top">
 τ=
2; 
dding: 0px;padding-bottom: 2px;" valign=3D"top" height=3D"15">
#933936">Mismatch-repair deficiency predicts response of solid tumors to PD=
-1 blockade

2"> 
dding: 0px;padding-right: 0px;" valign=3D"top">
 τ=
2; 
dding: 0px;padding-bottom: 2px;" valign=3D"top" height=3D"15">
#934050">Chi-Med steps closer to Chinese pharma first with drug filing
2"> 

le=3D"padding: 0px; padding-left: 5px; padding-top: 0px; padding-bottom: 5p=
x;" colspan=3D"2" align=3D"center">
infoinc.com/apha_daily/images/practice-trends.gif" vspace=3D"0" hspace=3D"0=
" border=3D"0" alt=3D"Practice & Trends" />
le=3D"padding: 0px; padding-left: 5px; padding-bottom: 5px;">
p://www.infoinc.com/apha_daily/images/library/1996/practice-14.jpg" alt=3D"=
logo" hspace=3D"0" vspace=3D"0" border=3D"0" style=3D"padding:0px;max-width=
:126px;" width=3D"126" />


padding: 5px;" id=3D"TDLinkBar" bgcolor=3D"#ffffff">
ellspacing=3D"0" cellpadding=3D"0" border=3D"0">=20=20=20=20=20=20=20=20=20=
=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=
=20=20=20=20=20=20=20=20




























dding: 0px;padding-right: 0px;" valign=3D"top">
 τ=
2; 
dding: 0px;padding-bottom: 2px;" valign=3D"top" height=3D"15">
#934035">Opioid dealers embrace the dark web to send deadly drugs
2"> 
dding: 0px;padding-right: 0px;" valign=3D"top">
 τ=
2; 
dding: 0px;padding-bottom: 2px;" valign=3D"top" height=3D"15">
#932936">Pfizer hikes U.S. prices of 91 drugs by average 20% in 2017
2"> 
dding: 0px;padding-right: 0px;" valign=3D"top">
 τ=
2; 
dding: 0px;padding-bottom: 2px;" valign=3D"top" height=3D"15">
#932435">Dietary supplement industry outlines new pedigree protocol
2"> 
dding: 0px;padding-right: 0px;" valign=3D"top">
 τ=
2; 
dding: 0px;padding-bottom: 2px;" valign=3D"top" height=3D"15">
#930493">Robotic pharmacy to open at Kirkland Cancer Center
2"> 

le=3D"padding: 0px; padding-left: 5px; padding-top: 0px; padding-bottom: 5p=
x;" colspan=3D"2" align=3D"center">
infoinc.com/apha_daily/images/laws-regs-rulings.gif" vspace=3D"0" hspace=3D=
"0" border=3D"0" alt=3D"Laws, Regs & Rulings" />
le=3D"padding: 0px; padding-left: 5px; padding-bottom: 5px;">
p://www.infoinc.com/apha_daily/images/library/1998/laws-6.jpg" alt=3D"logo"=
hspace=3D"0" vspace=3D"0" border=3D"0" style=3D"padding:0px;max-width:126p=
x;" width=3D"126" />


padding: 5px;" id=3D"TDLinkBar" bgcolor=3D"#ffffff">
ellspacing=3D"0" cellpadding=3D"0" border=3D"0">=20=20=20=20=20=20=20=20=20=
=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=
=20=20=20=20=20=20=20=20





















dding: 0px;padding-right: 0px;" valign=3D"top">
 τ=
2; 
dding: 0px;padding-bottom: 2px;" valign=3D"top" height=3D"15">
#934032">States lead the fight against Trump's contraception rollback
2"> 
dding: 0px;padding-right: 0px;" valign=3D"top">
 τ=
2; 
dding: 0px;padding-bottom: 2px;" valign=3D"top" height=3D"15">
#934068">NJ governor approves law expanding pharmacy access to opioid antid=
ote

2"> 
dding: 0px;padding-right: 0px;" valign=3D"top">
 τ=
2; 
dding: 0px;padding-bottom: 2px;" valign=3D"top" height=3D"15">
#933942">Lower drug costs still 'absolute priority' for Trump, Price saysa>
2"> 



r=3D"#ffffff" align=3D"left" valign=3D"top" colspan=3D"2"> 
inkBar" bgcolor=3D"#ffffff" width=3D"424">
ing=3D"0" border=3D"0">






g: 0px;">
apha_daily/images/news.gif" width=3D"424" height=3D"31" border=3D"0" alt=3D=
"News You Can Use" />
g: 0px;">
pacing=3D"0" cellpadding=3D"0" border=3D"0">























g: 0px;" width=3D"128"> 
g: 0px; padding-top: 0px; padding-bottom: 10px;" width=3D"128" valign=3D"to=
p">=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=
=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=
=20=20=20=09
://apha.msgfocus.com/c/1dDC6xiAmEvlJYjJE2yuZG9QJ" target=3D"_blank">c=3D"http://www.infoinc.com/apha_daily/images/pharmacy-today.gif" border=3D=
"0" alt=3D"" />

=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=
=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=
=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20
g: 10px; padding-top: 0px; padding-left: 10px;" valign=3D"top">=20=20=20=20=
=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=
=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=
=20=20



r>
//apha.msgfocus.com/c/1dDCawDVNnQQHX3VvBWQIELWk">FDA’s new codeine an=
d tramadol warning further restricts use in kids
//apha.msgfocus.com/c/1dDCivkCEQxQDUyjeKJyaC07w">Misuse and abuse of noncon=
trolled drugs: It’s not just prescription opioids anymore

g: 0px; padding-top: 0px; padding-bottom: 10px;" width=3D"128" valign=3D"to=
p">=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=
=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=
=20=20=20=09
://apha.msgfocus.com/c/1dDCmuFY5zTlBTiv6k7TTACd7" target=3D"_blank">c=3D"http://www.infoinc.com/apha_daily/images/drug-info-line.gif" border=3D=
"0" alt=3D"" />

=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=
=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=
=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20
g: 10px; padding-top: 0px; padding-left: 10px;" valign=3D"top">=20=20=20=20=
=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=
=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=
=20=20



//apha.msgfocus.com/c/1dDCqu1jwjeQzS2GXTwfCzeiI">FDA approves first generic=
s of atomoxetine (Strattera) for treatment of ADHD

g: 0px; padding-top: 0px; padding-bottom: 10px;" width=3D"128" valign=3D"to=
p">=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=
=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=
=20=20=20=09
://apha.msgfocus.com/c/1dDCutmEX2AlxQMSPsUBlxQoj" target=3D"_blank">c=3D"http://www.infoinc.com/apha_daily/images/japha.gif" border=3D"0" alt=
=3D"" />

=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=
=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=
=20=20=20=20=20=20=20=20=20=20=20=20=20
g: 10px; padding-top: 0px; padding-left: 10px;" valign=3D"top">=20=20=20=20=
=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=
=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=
=20=20



//apha.msgfocus.com/c/1dDCysI0nLVQvPx4H2iX4wstU">The impact of a retail pre=
scription synchronization program on medication adherence

g: 0px; padding-top: 0px; padding-bottom: 10px;" width=3D"128" valign=3D"to=
p">=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=
=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=
=20=20=20=09
://apha.msgfocus.com/c/1dDCCs3lOvhltOhgyBHiNv4zv" target=3D"_blank">c=3D"http://www.infoinc.com/apha_daily/images/Education_Icon.png" border=3D=
"0" alt=3D"" />

=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=
=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=
=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20
g: 10px; padding-top: 0px; padding-left: 10px;" valign=3D"top">=20=20=20=20=
=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=
=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=
=20=20



//apha.msgfocus.com/c/1dDCGroHfeCQrN1sqb5EwtGF6">Report of the APhA Stakeho=
lder Conference on Improving Patient Access to Injectable Medications
td>

g: 0px; padding-top: 0px; padding-bottom: 10px;" width=3D"128" valign=3D"to=
p">=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=
=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=
=20=20=20=09
://apha.msgfocus.com/c/1dDCKqK2FXYlpLLEhKu0fsiKH" target=3D"_blank">c=3D"http://www.infoinc.com/apha_daily/images/PT_Resources_Icon.png" border=
=3D"0" alt=3D"" />

=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=
=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=
=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20
g: 10px; padding-top: 0px; padding-left: 10px;" valign=3D"top">=20=20=20=20=
=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=
=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=
=20=20



//apha.msgfocus.com/c/1dDCOq5o6HjQnKvQ9jSlYqUQi">Resource Guide for Immuniz=
ation Services





inkBar" bgcolor=3D"#ffffff" width=3D"300" valign=3D"top">
ing=3D"0" border=3D"0">









g: 0px;" valign=3D"top">
HHpwVT" target=3D"_blank">s/16672_BOM-0617_3.png" hspace=3D"0" vspace=3D"0" border=3D"0" alt=3D"juneb=
om" />

kBar" bgcolor=3D"#ffffff" colspan=3D"2"> 
g: 0px;" align=3D"center" valign=3D"top">
com/apha_daily/images/latest-issue-head.gif" width=3D"300" height=3D"31" bo=
rder=3D"0" alt=3D"" />

g87w6E" target=3D"_blank">s/May-PT-Daily-300x250.png" hspace=3D"0" vspace=3D"0" border=3D"0" alt=3D"P=
T_May2017_Cover" />


r=3D"#ffffff" align=3D"left" valign=3D"top" colspan=3D"2"> 
inkBar" bgcolor=3D"#ffffff" valign=3D"top">=20=20=20=20=20=20=20=20=20=20=
=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=20=
=20=20=20=20=20=20=20=20=20=20
com/apha_daily/images/APhA.TopStory.gif" border=3D"0" alt=3D"Top Story" /><=
br>


Opioid Crisis Complicates GOP’s Health Law Push
Wa=
ll Street Journal (06/12/17) Nunn, Sharon


The nation&rsquo=
;s worsening opioid crisis has made key Republican senators hesitate to sup=
port legislation dismantling major portions of the Affordable Care Act (ACA=
). Several provisions of the ACA allowed millions of Americans seeking subs=
tance-abuse treatment to gain coverage, including through an expansion of t=
he Medicaid health program. But the House bill repealing the ACA, passed in=
early May, would roll back that Medicaid expansion beginning in 2020 and a=
llow insurance companies to charge some people with drug addictions higher =
premiums or deny them substance-abuse coverage. Concerns about those provis=
ions cut into Republican support for the replacement measure in the House. =
Of the 20 Republicans who voted against the House bill, 16 represent states=
that saw significant increases in drug-overdose death rates in recent year=
s. Now, the same concerns are emerging as a factor as the Senate takes up t=
he House bill and ponders how to change it. Some Republican senators are pu=
shing to wind down the Medicaid expansion funding more slowly. They would h=
ave the rollback occur over a 7-year window beginning in 2020. Lawmakers ar=
e also looking at including a pot of money specifically for opioid treatmen=
t, according to Republican senate aides.




=20
com/apha_daily/images/drugs-diseases.gif" border=3D"0" alt=3D"Drugs & Disea=
ses" />



Seizing on opioid crisis, a drug maker lobbies hard for its productb>
New York Times (06/12/17) Goodnough, Abby; Zernike, Kate />
Drug manufacturer Alkermes has spent years targeting lawmakers a=
nd law enforcement strategies, lobbying them about the benefits of its nalt=
rexone (Vivitrol) drug as a treatment for opioid addiction. Now, its sales =
and profile are rising fast, thanks to its manufacturers’ shrewd use =
of political connections, and despite scant science to prove the drug&rsquo=
;s efficacy. Last month, HHS Secretary Tom Price, praised it as the future =
of opioid addiction treatment after visiting the company’s plant in O=
hio. He set off a furor among subs

  1. 2017-06-02 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] Neural Sciences and Coding
  2. 2017-06-02 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] Neural Sciences and Coding
  3. 2017-06-02 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] Blue Colar Coders
  4. 2017-06-03 Rick Moen <rick-at-linuxmafia.com> Subject: [Hangout - NYLXS] (forw) Re: [skeptic] FWD: Fleeing the Paris
  5. 2017-06-03 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] Movie of the Weeks
  6. 2017-06-04 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] If you see something, say something!
  7. 2017-06-05 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] Healthcare coding
  8. 2017-06-05 Gabor Szabo <gabor-at-szabgab.com> Subject: [Hangout - NYLXS] [Perlweekly] #306 - Perl 5.26.0 is now available!
  9. 2017-06-05 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] Project for PhP business app
  10. 2017-06-06 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] github thread with RMS
  11. 2017-06-05 James E Keenan <jkeenan-at-pobox.com> Subject: [Hangout - NYLXS] TPC::NA::2017: Propose lightning talks
  12. 2017-06-05 James E Keenan <jkeenan-at-pobox.com> Subject: [Hangout - NYLXS] TPC 2017 schedule has been posted; Registration;
  13. 2017-06-05 Glenn Randers-Pehrson <glennrp-at-gmail.com> Subject: [Hangout - NYLXS] [png-mng-implement] Off-by-one bug in libpng16
  14. 2017-06-06 mrbrklyn <mrbrklyn-at-panix.com> Subject: [Hangout - NYLXS] London lowdown
  15. 2017-06-06 mrbrklyn <mrbrklyn-at-panix.com> Re: [Hangout - NYLXS] [png-mng-implement] Off-by-one bug in
  16. 2017-06-06 Rick Moen <rick-at-linuxmafia.com> Re: [Hangout - NYLXS] London lowdown
  17. 2017-06-06 Rick Moen <rick-at-linuxmafia.com> Re: [Hangout - NYLXS] London lowdown
  18. 2017-06-06 ISOC-NY announcements <announce-at-lists.isoc-ny.org> Subject: [Hangout - NYLXS] =?utf-8?q?=5Bisoc-ny=5D_Call_for_Proposals_?=
  19. 2017-06-06 Glenn Randers-Pehrson <glennrp-at-gmail.com> Subject: [Hangout - NYLXS] [png-mng-implement] libpng-1.6.30beta04 is
  20. 2017-06-06 andy bang <andy.bang-at-oracle.com> Subject: [Hangout - NYLXS] MySQL Enterprise Monitor 3.4.1 has been released
  21. 2017-06-07 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] Fwd: tx path circular buffer
  22. 2017-06-07 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] reactjs
  23. 2017-06-07 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] Midevil Castles, the Maginot Line, and now this
  24. 2017-06-07 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] The Foreign Policy Faliure that keeps on giving
  25. 2017-06-07 Ruben Safir <mrbrklyn-at-panix.com> Re: [Hangout - NYLXS] The Foreign Policy Faliure that keeps on
  26. 2017-06-07 Ruben Safir <mrbrklyn-at-panix.com> Subject: [Hangout - NYLXS] The Inevitable Connection Between Artificial
  27. 2017-06-07 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] Survailence Cameras on the cloud
  28. 2017-06-07 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] AI and surveillance
  29. 2017-06-07 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] ISIS may be using DJI consumer drones for
  30. 2017-06-07 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] Snowden
  31. 2017-06-07 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] US envoy Haley berates UN rights council,
  32. 2017-06-07 Ruben Safir <ruben-at-mrbrklyn.com> Re: [Hangout - NYLXS] London lowdown
  33. 2017-06-07 Ruben Safir <mrbrklyn-at-panix.com> Re: [Hangout - NYLXS] London lowdown
  34. 2017-06-07 Ruben Safir <ruben-at-mrbrklyn.com> Re: [Hangout - NYLXS] London lowdown
  35. 2017-06-07 Rick Moen <rick-at-linuxmafia.com> Re: [Hangout - NYLXS] London lowdown
  36. 2017-06-07 Greg KH <greg-at-kroah.com> Re: [Hangout - NYLXS] tx path circular buffer
  37. 2017-06-07 ruth02-at-web.de Re: [Hangout - NYLXS] [Hangout of NYLXS] - Rick M girlfriend in news
  38. 2017-06-07 Rick Moen <rick-at-linuxmafia.com> Re: [Hangout - NYLXS] [Hangout of NYLXS] - Rick M girlfriend in news
  39. 2017-06-07 Ruben Safir <mrbrklyn-at-panix.com> Re: [Hangout - NYLXS] [Hangout of NYLXS] - Rick M girlfriend in news
  40. 2017-06-07 Rick Moen <rick-at-linuxmafia.com> Re: [Hangout - NYLXS] [Hangout of NYLXS] - Rick M girlfriend in news
  41. 2017-06-07 Ruben Safir <ruben-at-mrbrklyn.com> Re: [Hangout - NYLXS] [Hangout of NYLXS] - Rick M girlfriend in news
  42. 2017-06-07 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] Human rights and the UN
  43. 2017-06-08 Rick Moen <rick-at-linuxmafia.com> Re: [Hangout - NYLXS] [Hangout of NYLXS] - Rick M girlfriend in news
  44. 2017-06-08 mrbrklyn <mrbrklyn-at-panix.com> Subject: [Hangout - NYLXS] CT Scans and 3d printing
  45. 2017-06-08 Ruben Safir <ruben-at-mrbrklyn.com> Re: [Hangout - NYLXS] [Hangout of NYLXS] - Rick M girlfriend in news
  46. 2017-06-08 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] the surveillance state
  47. 2017-06-08 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] resume google trick
  48. 2017-06-08 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] Coding Repos
  49. 2017-06-08 From: "Mancini, Sabin (DFS)" <Sabin.Mancini-at-dfs.ny.gov> Re: [Hangout - NYLXS] [Hangout of NYLXS] : Debian derivative that
  50. 2017-06-08 Rick Moen <rick-at-linuxmafia.com> Re: [Hangout - NYLXS] [Hangout of NYLXS] : Debian derivative that
  51. 2017-06-09 Ruben Safir <ruben-at-mrbrklyn.com> Re: [Hangout - NYLXS] [Hangout of NYLXS] : Debian derivative that
  52. 2017-06-09 Ruben Safir <ruben-at-mrbrklyn.com> Re: [Hangout - NYLXS] [Hangout of NYLXS] - Rick M girlfriend in news
  53. 2017-06-09 Ruben Safir <ruben-at-mrbrklyn.com> Re: [Hangout - NYLXS] [Hangout of NYLXS] : Debian derivative that
  54. 2017-06-09 Rick Moen <rick-at-linuxmafia.com> Re: [Hangout - NYLXS] [Hangout of NYLXS] - Rick M girlfriend in news
  55. 2017-06-09 Rick Moen <rick-at-linuxmafia.com> Re: [Hangout - NYLXS] [Hangout of NYLXS] : Debian derivative that
  56. 2017-06-09 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] Abbott Scam
  57. 2017-06-09 Rick Moen <rick-at-linuxmafia.com> Re: [Hangout - NYLXS] Abbott Scam
  58. 2017-06-09 Rick Moen <rick-at-linuxmafia.com> Re: [Hangout - NYLXS] Abbott Scam
  59. 2017-06-09 Rick Moen <rick-at-linuxmafia.com> Re: [Hangout - NYLXS] Abbott Scam
  60. 2017-06-09 Rick Moen <rick-at-linuxmafia.com> Re: [Hangout - NYLXS] Abbott Scam
  61. 2017-06-10 ruth02-at-web.de Re: [Hangout - NYLXS] [Hangout of NYLXS] - Rick M girlfriend in
  62. 2017-06-10 Rick Moen <rick-at-linuxmafia.com> Re: [Hangout - NYLXS] [Hangout of NYLXS] - Rick M girlfriend in
  63. 2017-06-10 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] Movie of the Week
  64. 2017-06-10 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] Abbott Scam
  65. 2017-06-10 Rick Moen <rick-at-linuxmafia.com> Re: [Hangout - NYLXS] Abbott Scam
  66. 2017-06-11 Ruben Safir <ruben-at-mrbrklyn.com> Re: [Hangout - NYLXS] Abbott Scam
  67. 2017-06-11 Ruben Safir <mrbrklyn-at-panix.com> Re: [Hangout - NYLXS] Abbott Scam
  68. 2017-06-11 Ruben Safir <mrbrklyn-at-panix.com> Re: [Hangout - NYLXS] Abbott Scam
  69. 2017-06-11 Ruben Safir <mrbrklyn-at-panix.com> Re: [Hangout - NYLXS] Abbott Scam
  70. 2017-06-11 Ruben Safir <mrbrklyn-at-panix.com> Re: [Hangout - NYLXS] Abbott Scam
  71. 2017-06-11 Ruben Safir <mrbrklyn-at-panix.com> Re: [Hangout - NYLXS] Abbott Scam
  72. 2017-06-11 Ruben Safir <mrbrklyn-at-panix.com> Re: [Hangout - NYLXS] Abbott Scam - tightening the nose on the
  73. 2017-06-11 Ruben Safir <mrbrklyn-at-panix.com> Subject: [Hangout - NYLXS] PBMs and Rebates... lets not just blame Abbott
  74. 2017-06-11 Ruben Safir <mrbrklyn-at-panix.com> Re: [Hangout - NYLXS] PBMs and Rebates... lets not just blame Abbott
  75. 2017-06-11 Ruben Safir <mrbrklyn-at-panix.com> Re: [Hangout - NYLXS] PBMs and Rebates... lets not just blame Abbott
  76. 2017-06-11 Ruben Safir <mrbrklyn-at-panix.com> Re: [Hangout - NYLXS] PBMs and Rebates... lets not just blame Abbott
  77. 2017-06-11 Ruben Safir <mrbrklyn-at-panix.com> Re: [Hangout - NYLXS] PBMs and Rebates... lets not just blame Abbott
  78. 2017-06-11 Ruben Safir <mrbrklyn-at-panix.com> Re: [Hangout - NYLXS] PBMs and Rebates... lets not just blame Abbott
  79. 2017-06-11 Ruben Safir <mrbrklyn-at-panix.com> Subject: [Hangout - NYLXS] Abbotts lies in its markets
  80. 2017-06-11 Rick Moen <rick-at-linuxmafia.com> Re: [Hangout - NYLXS] Abbott Scam
  81. 2017-06-11 Ruben Safir <mrbrklyn-at-panix.com> Subject: [Hangout - NYLXS] Time to end the kickbacks and the control
  82. 2017-06-11 Ruben Safir <mrbrklyn-at-panix.com> Re: [Hangout - NYLXS] Time to end the kickbacks and the control
  83. 2017-06-11 Ruben Safir <ruben-at-mrbrklyn.com> Re: [Hangout - NYLXS] Abbott Scam
  84. 2017-06-11 Ruben Safir <ruben-at-mrbrklyn.com> Re: [Hangout - NYLXS] Abbott Scam
  85. 2017-06-11 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] Fwd: Re: mod_perl and cgi-script handler
  86. 2017-06-11 From: "Ruben.Safir" <ruben.safir-at-my.liu.edu> Subject: [Hangout - NYLXS] Language Workshops
  87. 2017-06-11 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] Suplementry IT training
  88. 2017-06-11 Ruben Safir <mrbrklyn-at-panix.com> Subject: [Hangout - NYLXS] we'll always have Paris
  89. 2017-06-12 From: "Mancini, Sabin (DFS)" <Sabin.Mancini-at-dfs.ny.gov> Re: [Hangout - NYLXS] Abbott Scam: Wow. Ruben is pretty hot on this
  90. 2017-06-11 Gabor Szabo <gabor-at-szabgab.com> Subject: [Hangout - NYLXS] [Perlweekly] #307 - The Perl Conference is nearly
  91. 2017-06-12 From: "APhA's Pharmacy Today" <PTdaily-at-aphanet.org> Subject: [Hangout - NYLXS] =?utf-8?q?June_12=2C_2017=3A_Opioid_Crisis_Comp?=
  92. 2017-06-12 From: "soledad.esteban" <soledad.esteban-at-icp.cat> Subject: [Hangout - NYLXS] [dinosaur] International course on Scientific
  93. 2017-06-13 From: "Chaim Desser" <career-at-poelgroup.com> Subject: [Hangout - NYLXS] position to review
  94. 2017-06-13 James E Keenan <jkeenan-at-pobox.com> Subject: [Hangout - NYLXS] TPC here and there
  95. 2017-06-14 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] busy today with corruption on linkedin
  96. 2017-06-15 From: "Yi Qian, IEEE ICC'18 TPC Chair" <noreply-at-comsoc.org> Subject: [Hangout - NYLXS] IEEE ICC'18 Call for Workshop Proposals &
  97. 2017-06-17 ruth02-at-web.de Re: [Hangout - NYLXS] [Hangout of NYLXS] - Guarantee- I am not in
  98. 2017-06-19 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] MTA extortion
  99. 2017-06-19 Mark Halegua <phantom21-at-mindspring.com> Re: [Hangout - NYLXS] MTA extortion
  100. 2017-06-19 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] Jobs
  101. 2017-06-20 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] Jobs
  102. 2017-06-20 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] Movie of the Week
  103. 2017-06-23 Kevin Zheng <kevinz5000-at-gmail.com> Subject: [Hangout - NYLXS] [crossfire] Release proposal
  104. 2017-06-23 Mark Wedel <mwedel-at-sonic.net> Re: [Hangout - NYLXS] [crossfire] Release proposal
  105. 2017-06-23 Rick Tanner <leaf-at-real-time.com> Re: [Hangout - NYLXS] [crossfire] Release proposal
  106. 2017-06-23 Kevin Zheng <kevinz5000-at-gmail.com> Re: [Hangout - NYLXS] [crossfire] Release proposal
  107. 2017-06-23 Kevin Zheng <kevinz5000-at-gmail.com> Re: [Hangout - NYLXS] [crossfire] Release proposal
  108. 2017-06-23 Matthew Giassa <matthew-at-giassa.net> Re: [Hangout - NYLXS] [crossfire] Release proposal
  109. 2017-06-23 Preston Crow <pc-crossfire06-at-crowcastle.net> Subject: [Hangout - NYLXS] [crossfire] Crossfire maps idea
  110. 2017-06-23 David Hurst <davidnicholashurst-at-gmail.com> Re: [Hangout - NYLXS] [crossfire] Release proposal
  111. 2017-06-23 Rick Tanner <leaf-at-real-time.com> Re: [Hangout - NYLXS] [crossfire] Release proposal
  112. 2017-06-23 Ruben Safir <ruben-at-mrbrklyn.com> Re: [Hangout - NYLXS] [crossfire] Release proposal
  113. 2017-06-23 From: "Meaningful Beauty" <MeaningfulBeauty-at-islerpatto.stream> Subject: [Hangout - NYLXS] Youthful looking Skin + Free-Shipping
  114. 2017-06-23 David Hurst <davidnicholashurst-at-gmail.com> Re: [Hangout - NYLXS] [crossfire] Release proposal
  115. 2017-06-25 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] TED on the threat of AI in the Military
  116. 2017-06-26 Gabor Szabo <gabor-at-szabgab.com> Subject: [Hangout - NYLXS] [Perlweekly] #309 - csvgrep and the recipe for
  117. 2017-06-26 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] Fishing images
  118. 2017-06-26 opensuse-security-at-opensuse.org Subject: [Hangout - NYLXS] [security-announce] SUSE-SU-2017:1669-1:
  119. 2017-06-26 opensuse-security-at-opensuse.org Subject: [Hangout - NYLXS] [security-announce] openSUSE-SU-2017:1685-1:
  120. 2017-06-26 Ruben Safir <ruben-at-mrbrklyn.com> Re: [Hangout - NYLXS] Fishing images
  121. 2017-06-26 Rick Tanner <leaf-at-real-time.com> Re: [Hangout - NYLXS] [crossfire] Release proposal
  122. 2017-06-26 Rick Tanner <leaf-at-real-time.com> Subject: [Hangout - NYLXS] [crossfire] Expanded World Map (was: Release
  123. 2017-06-26 Rick Tanner <leaf-at-real-time.com> Re: [Hangout - NYLXS] [crossfire] Crossfire maps idea
  124. 2017-06-27 From: "S." <sman356-at-yahoo.com> Subject: [Hangout - NYLXS] Score: 9 - 0 ! WIN ! on SCOTUS
  125. 2017-06-23 From: "NYU Langone Careers" <nyumccareers-at-symphonytalent.com> Subject: [Hangout - NYLXS] Follow up from NYU Langone Medical Center
  126. 2017-06-28 Ruben Safir <mrbrklyn-at-panix.com> Subject: [Hangout - NYLXS] family in need
  127. 2017-06-28 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] A train derailment
  128. 2017-06-28 Ruben Safir <ruben-at-mrbrklyn.com> Re: [Hangout - NYLXS] A train derailment
  129. 2017-06-28 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] Must See website
  130. 2017-06-28 Ruben Safir <ruben-at-mrbrklyn.com> Re: [Hangout - NYLXS] A train derailment
  131. 2017-06-28 Ruben Safir <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] Fwd: [manjaro-general] Manjaro-Architect ISO
  132. 2017-06-29 ruben <ruben-at-mrbrklyn.com> Subject: [Hangout - NYLXS] time to put down the phone
  133. 2017-06-29 From: "Mancini, Sabin (DFS)" <Sabin.Mancini-at-dfs.ny.gov> Re: [Hangout - NYLXS] Lottery programmer rigs systems in 4 states,
  134. 2017-06-30 Ruben Safir <mrbrklyn-at-panix.com> Subject: [Hangout - NYLXS] Dinosaur found in Amber

NYLXS are Do'ers and the first step of Doing is Joining! Join NYLXS and make a difference in your community today!